Macleods Pharmaceuticals Ltd is recalling approximately 15,744 30-count bottles of Olanzapine (olanzapine) Tablets, USP 2.5 mg. This prescription medication is being recalled because testing revealed that the tablets failed to meet required specifications for impurities and degradation. Consumers who are taking this medication should consult their doctor or pharmacist for advice on their treatment.
Medication that fails impurity or degradation specifications may be less effective or could potentially expose patients to unexpected chemical compounds over time. While specific incidents were not reported, using degraded drugs can impact the management of the underlying medical condition.
You have 2 options:
Manufactured by Macleods Pharmaceuticals, Ltd. Baddi Himachal Pradesh, INDIA.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.